DEAD box 1: A novel and independent prognostic marker for early recurrence in breast cancer

Breast Cancer Research and Treatment

Volumn 127, Issue 1, 2011, Pages 53-63

  Germain, Devon R ^a   Graham, Kathryn ^a   Glubrecht, Darryl D ^a   Hugh, Judith C ^a   MacKey, John R ^a   Godbout, Roseline ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Breast cancer; DEAD box 1; Early recurrence; Gene expression; Prognostic marker; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; DEAD BOX PROTEIN; DEAD BOX PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; RNA; SINGLE STRANDED DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; FOLLOW UP; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR PROBE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SPACE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN TRANSPORT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954948336     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0943-7     Document Type: Article

References (40)

1. P Porter 2008 "Westernizing" women's risks? Breast cancer in lower-income countries N Engl J Med 358 213 216 18199859 10.1056/NEJMp0708307 1:CAS:528:DC%2BD1cXms1Ogug%3D%3D
2. SE Jones 2008 Metastatic breast cancer: the treatment challenge Clin Breast Cancer 8 224 233 18650152 10.3816/CBC.2008.n.025 1:CAS:528: DC%2BD1cXovFCiu7s%3D (Pubitemid 351962143)
3. J Bergh PE Jonsson B Glimelius P Nygren 2001 A systematic overview of chemotherapy effects in breast cancer Acta Oncol 40 253 281 11441936 10.1080/02841860151116349 1:STN:280:DC%2BD3MzovVCjuw%3D%3D (Pubitemid 32590835)
4. S Lopez-Tarruella M Martin 2009 Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer Breast Cancer Res 11 204 19344489 10.1186/bcr2226
5. A Barnadas M Gil P Sanchez-Rovira A Llombart E Adrover LG Estevez J De la Haba L Calvo 2008 Neoadjuvant endocrine therapy for breast cancer: past, present and future Anticancer Drugs 19 339 347 18454044 10.1097/CAD. 0b013e3282f97f75 1:CAS:528:DC%2BD1cXjvFemsL4%3D
6. R Fossati C Confalonieri V Torri E Ghislandi A Penna V Pistotti A Tinazzi A Liberati 1998 Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women J Clin Oncol 16 3439 3460 9779724 1:CAS:528:DyaK1cXmvFGrurs%3D (Pubitemid 28481644)
7. MC Cheang SK Chia D Voduc D Gao S Leung J Snider M Watson S Davies PS Bernard JS Parker CM Perou MJ Ellis TO Nielsen 2009 Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 736 750 19436038 10.1093/jnci/djp082 1:CAS:528:DC%2BD1MXmtlyit74%3D
8. C Fan DS Oh L Wessels B Weigelt DS Nuyten AB Nobel LJ van't Veer CM Perou 2006 Concordance among gene-expression-based predictors for breast cancer N Engl J Med 355 560 569 16899776 10.1056/NEJMoa052933 1:CAS:528: DC%2BD28XotVKnur4%3D (Pubitemid 44200649)
9. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
10. J Hugh J Hanson MC Cheang TO Nielsen CM Perou C Dumontet J Reed M Krajewska I Treilleux M Rupin E Magherini J Mackey M Martin C Vogel 2009 Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial J Clin Oncol 27 1168 1176 19204205 10.1200/JCO.2008.18.1024 1:CAS:528:DC%2BD1MXktFKhs7Y%3D
11. B Kreike M van Kouwenhove H Horlings B Weigelt H Peterse H Bartelink MJ van de Vijver 2007 Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Breast Cancer Res 9 R65 17910759 10.1186/bcr1771 (Pubitemid 350187481)
12. JD Brenton LA Carey AA Ahmed C Caldas 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 7350 7360 16145060 10.1200/JCO.2005.03.3845 1:CAS:528: DC%2BD2MXhtF2nsLrJ (Pubitemid 46202348)
13. VE Chiuri G Leo V Lorusso 2007 Clinical and therapeutic perspectives of gene expression profiling for breast cancer Ann Oncol 18 Suppl 6 Vi58 Vi62 17591834 10.1093/annonc/mdm226
14. C Oakman S Bessi E Zafarana F Galardi L Biganzoli A Di Leo 2009 Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer Breast Cancer Res 11 205 19435470 10.1186/bcr2238
15. ZK Stadler SE Come 2009 Review of gene-expression profiling and its clinical use in breast cancer Crit Rev Oncol Hematol 69 1 11 18614375 10.1016/j.critrevonc.2008.05.004
16. EA Slodkowska JS Ross 2009 MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients Expert Rev Mol Diagn 9 417 422 19580427 10.1586/erm.09.32
17. KS Albain WE Barlow S Shak GN Hortobagyi RB Livingston IT Yeh P Ravdin R Bugarini FL Baehner NE Davidson GW Sledge EP Winer C Hudis JN Ingle EA Perez KI Pritchard L Shepherd JR Gralow C Yoshizawa DC Allred CK Osborne DF Hayes 2010 Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Lancet Oncol 11 55 65 20005174 10.1016/S1470-2045(09)70314-6 1:CAS:528: DC%2BC3cXjslKrtQ%3D%3D
18. Mook S, Schmidt MK, Weigelt B, Kreike B, Eekhout I, van de Vijver MJ, Glas AM, Floore A, Rutgers EJ, van 't Veer LJ (2009) The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. Ann Oncol. doi: 10.1093/annonc/mdp388
19. P Linder 2006 Dead-box proteins: a family affair-active and passive players in RNP-remodeling Nucleic Acids Res 34 4168 4180 16936318 10.1093/nar/gkl468 1:CAS:528:DC%2BD28XhtVOmur3E (Pubitemid 44542196)
20. R Godbout J Squire 1993 Amplification of a DEAD box protein gene in retinoblastoma cell lines Proc Natl Acad Sci USA 90 7578 7582 7689221 10.1073/pnas.90.16.7578 1:CAS:528:DyaK2cXlvVGk (Pubitemid 23249993)
21. JA Squire PS Thorner S Weitzman JD Maggi P Dirks J Doyle M Hale R Godbout 1995 Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma Oncogene 10 1417 1422 7731693 1:CAS:528:DyaK2MXltVGjtbs%3D
22. CF Manohar HR Salwen GM Brodeur SL Cohn 1995 Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma Genes Chromosomes Cancer 14 196 203 8589036 10.1002/gcc.2870140307 1:CAS:528:DyaK28Xis1Kjug%3D%3D
23. RE George RM Kenyon AG McGuckin AJ Malcolm AD Pearson J Lunec 1996 Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group Oncogene 12 1583 1587 8622876 1:CAS:528:DyaK28Xis12ntLY%3D (Pubitemid 26132046)
24. K Tanaka S Okamoto Y Ishikawa H Tamura T Hara 2009 DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes Oncogene 28 2142 2151 19398953 10.1038/onc.2009.89 1:CAS:528:DC%2BD1MXltV2nsrc%3D
25. KE Zinsmaier KK Eberle E Buchner N Walter S Benzer 1994 Paralysis and early death in cysteine string protein mutants of Drosophila Science 263 977 980 8310297 10.1126/science.8310297 1:CAS:528:DyaK2cXhvVOksr4%3D (Pubitemid 24094564)
26. S Bleoo X Sun MJ Hendzel JM Rowe M Packer R Godbout 2001 Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3-end processing of pre-MRNA Mol Biol Cell 12 3046 3059 11598190 1:CAS:528: DC%2BD3MXns1Chtr4%3D (Pubitemid 33062960)
27. Y Kanai N Dohmae N Hirokawa 2004 Kinesin transports RNA: isolation and characterization of an RNA-transporting granule Neuron 43 513 525 15312650 10.1016/j.neuron.2004.07.022 1:CAS:528:DC%2BD2cXnsVeitbs%3D (Pubitemid 39094678)
28. J Fang S Kubota B Yang N Zhou H Zhang R Godbout RJ Pomerantz 2004 A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev Virology 330 471 480 15567440 10.1016/j.virol.2004.09.039 1:CAS:528: DC%2BD2cXhtVaks7bI (Pubitemid 39572852)
29. L Li EA Monckton R Godbout 2008 A role for DEAD box 1 at DNA double-strand breaks Mol Cell Biol 28 6413 6425 18710941 10.1128/MCB.01053-08 1:CAS:528:DC%2BD1cXht1CitL7O
30. L Li K Roy S Katyal X Sun S Bleoo R Godbout 2006 Dynamic nature of cleavage bodies and their spatial relationship to DDX1 bodies, Cajal bodies, and gems Mol Biol Cell 17 1126 1140 16371507 10.1091/mbc.E05-08-0768 1:CAS:528:DC%2BD28XltlSqt7s%3D (Pubitemid 43376535)
31. R Godbout M Packer W Bie 1998 Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines J Biol Chem 273 21161 21168 9694872 10.1074/jbc.273.33.21161 1:CAS:528:DyaK1cXlsFOrsbY%3D (Pubitemid 28385405)
32. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2006 REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235 16932852 10.1007/s10549-006-9242-8 (Pubitemid 44631925)
33. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687-1717
34. Y Sunden S Semba T Suzuki Y Okada Y Orba K Nagashima T Umemura H Sawa 2007 Identification of DDX1 as a JC virus transcriptional control region-binding protein Microbiol Immunol 51 327 337 17380053 10.1111/j.1574-695X.2007.00309.x 1:CAS:528:DC%2BD2sXkvVSgtrk%3D (Pubitemid 47547507)
35. ME Bordeleau J Matthews JM Wojnar L Lindqvist O Novac E Jankowsky N Sonenberg P Northcote P Teesdale-Spittle J Pelletier 2005 Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation Proc Natl Acad Sci USA 102 10460 10465 16030146 10.1073/pnas.0504249102 1:CAS:528:DC%2BD2MXntVSit7Y%3D (Pubitemid 41061576)
36. HV Erkizan Y Kong M Merchant S Schlottmann JS Barber-Rotenberg L Yuan OD Abaan TH Chou S Dakshanamurthy ML Brown A Uren JA Toretsky 2009 A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma Nat Med 15 750 756 19584866 10.1038/nm.1983 1:CAS:528:DC%2BD1MXotlSntrk%3D
37. FV Fuller-Pace S Ali 2008 The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): novel transcriptional co-regulators Biochem Soc Trans 36 609 612 18631126 10.1042/BST0360609 1:CAS:528:DC%2BD1cXoslClt7o%3D
38. Wortham NC, Ahamed E, Nicol SM, Thomas RS, Periyasamy M, Jiang J, Ochocka AM, Shousha S, Huson L, Bray SE, Coombes RC, Ali S, Fuller-Pace FV (2009) The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene. doi: 10.1038/onc.2009.261
39. F Lin R Wang JJ Shen X Wang P Gao K Dong HZ Zhang 2008 Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo Cancer Biol Ther 7 1669 1676 18769115 1:CAS:528:DC%2BD1cXhsFWktLrN
40. B Cho Y Lim DY Lee SY Park H Lee WH Kim H Yang YJ Bang DI Jeoung 2002 Identification and characterization of a novel cancer/testis antigen gene CAGE Biochem Biophys Res Commun 292 715 726 11922625 10.1006/bbrc.2002.6701 1:CAS:528:DC%2BD38XitlGmsr8%3D (Pubitemid 34681118)